185 related articles for article (PubMed ID: 19558260)
1. Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.
Christiansen SR; Broniscer A; Panetta JC; Stewart CF
Pharmacotherapy; 2009 Jul; 29(7):858-66. PubMed ID: 19558260
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.
Broniscer A; Baker SJ; Stewart CF; Merchant TE; Laningham FH; Schaiquevich P; Kocak M; Morris EB; Endersby R; Ellison DW; Gajjar A
Clin Cancer Res; 2009 Jan; 15(2):701-7. PubMed ID: 19147777
[TBL] [Abstract][Full Text] [Related]
3. Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.
Geoerger B; Hargrave D; Thomas F; Ndiaye A; Frappaz D; Andreiuolo F; Varlet P; Aerts I; Riccardi R; Jaspan T; Chatelut E; Le Deley MC; Paoletti X; Saint-Rose C; Leblond P; Morland B; Gentet JC; Méresse V; Vassal G;
Neuro Oncol; 2011 Jan; 13(1):109-18. PubMed ID: 20974795
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
[TBL] [Abstract][Full Text] [Related]
5. Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis.
Giguere-Rich C; Mathew A; Reid E; Autore K; Guill MF
Nutr Clin Pract; 2018 Apr; 33(2):286-294. PubMed ID: 29658186
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
Nicolo M; Stratton KW; Rooney W; Boullata J
Nutr Clin Pract; 2013 Aug; 28(4):485-9. PubMed ID: 23753650
[TBL] [Abstract][Full Text] [Related]
9. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.
Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C
J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970
[TBL] [Abstract][Full Text] [Related]
10. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
11. Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis.
Wooldridge JL; Schaeffer D; Jacobs D; Thieroff-Ekerdt R
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):612-5. PubMed ID: 25050848
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
Littlewood JM; Wolfe SP; Conway SP
Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
[TBL] [Abstract][Full Text] [Related]
13. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
15. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
Mischler EH; Parrell S; Farrell PM; Odell GB
Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies of pediatric malabsorption syndromes].
Hosoyamada T
Fukuoka Igaku Zasshi; 2006 Nov; 97(11):322-50. PubMed ID: 17228786
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.
Preusser M; Gelpi E; Rottenfusser A; Dieckmann K; Widhalm G; Dietrich W; Bertalanffy A; Prayer D; Hainfellner JA; Marosi C
J Neurooncol; 2008 Sep; 89(2):211-8. PubMed ID: 18458820
[TBL] [Abstract][Full Text] [Related]
19. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
